Analytical Data
-
Gene name
Gastrokine 1
- Application
-
Alternative Names
CA11; AMP18; BRICD1; FOV; Foveolin; 18 kDa antrum mucosa protein
-
Species
Pig
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q8HYA9
-
Expression Region
Asn40~Ser190
-
Molecular Weight
20/18kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Gastrokine 1 (Gkn1) is a protein primarily expressed in the gastric epithelium and has garnered interest due to its potential role in gastrointestinal health and disease. Researchers have found that Gastrokine 1 is involved in the regulation of gastric mucosal integrity and may play a protective role against inflammation and infection, particularly in the context of conditions like gastritis and gastric ulcers. Additionally, studies have indicated that Gkn1 could be implicated in the pathogenesis of gastric cancers, making it a target for therapeutic intervention. The recombinant form of Gastrokine 1 is being explored for its biochemical properties and functional applications, including its potential as a biomarker for gastric diseases and its role in promoting healing and regeneration of the gastric lining. Ongoing research aims to elucidate the mechanisms by which Gkn1 exerts its effects, as well as to assess its therapeutic efficacy in preclinical models. Understanding Gastrokine 1’s function at the molecular level could lead to novel strategies for treating gastric disorders and improving patient outcomes. Overall, the study of recombinant Gastrokine 1 is an exciting area of research that bridges molecular biology and clinical applications in gastroenterology.
